TF

Tara Franks

Chief Operating Officer

Translational Drug Development (TD2)

Scottsdale, Arizona


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Translational Drug Development (TD2)
Industry
research
Employees
150.0
Seniority
C suite
Annual Revenue
15000000.0
Latest Funding
Other

Technologies

Outlook Microsoft Office 365 WP Engine Hubspot Google Tag Manager Facebook Widget Linkedin Widget Linkedin Login Shutterstock Google Font API Hotjar Jobscore DoubleClick Conversion Facebook Login (Connect) Linkedin Marketing Solutions DoubleClick Bootstrap Framework Google Dynamic Remarketing Google AdSense WordPress.org Mobile Friendly Remote

Keywords

xenograft models bioanalytical services primary gbm panel ariiel radiation lab oncology clinical trial management ind filings regulatory affairs fda interactions data management preclinical oncology translational drug development flow cytometry adc drug development radiopharmaceutical drug development syngeneic studies immunooncology pdx models humanized pdx research services clinical trial services study design protocol development patient identification site management regulatory support biostatistics pharmacovigilance medical monitoring etmf management quality assurance therapeutic areas radiolabeled pharmaceuticals hematologic malignancies full program management consulting protocol design program budget executive plan trial enablement regulatory writing submission filing gap analysis model systems syngeneic tumor models orthotopic tumor models patient derived xenograft humanized mouse models diet-induced obesity models adoptive cell therapy models dmpk/adme services in vivo characterization in vitro characterization optical imaging therapeutic evaluation antibody drug conjugates clinical study management pk/adme innovative cancer therapies precision oncology oncology cro clinical trial metrics data quality assurance adverse event reconciliation system validation cdisc compliance oncology drug development contract research organization clinical trial management preclinical services advanced flow cytometry targeted therapies immuno-oncology antibody-drug conjugates radiopharmaceuticals precision medicine clinical trial execution biomarker discovery translational research community oncology practices patient access drug development ecosystem strategic collaboration scientific innovation patient outcomes clinical trial sites biopharmaceutical companies oncology research operational excellence global clinical trials patient-derived xenografts pharmacokinetics safety profiling fda compliance oncology therapies cancer treatment acceleration

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans